Home / Rupatadine / Canada
CA ATC R06AX28 · updated 2 Nov 2026
Rupatadine shortage in Canada
Is there a Rupatadine shortage in Canada?
Yes. As of 2 Nov 2026, 2 Rupatadine products are reported short in Canada, the first since 15 Sep 2026. The company estimate for the return is 9 Nov 2026 (latest 13 Nov 2026). Main reason: distribution or logistics.
Also short in Italy, Czechia. All countries.
Affected products in Canada
| Country | Product | Company | Since | Expected back | Reason |
|---|---|---|---|---|---|
| CA | RUPALL (120 mL) | MEDEXUS PHARMACEUTICALS INC. | 15 Sep 2026 | 9 Nov 2026 | Distribution or logistics Delay in shipping of the drug |
| CA | APO-RUPATADINE (100 BTL) | APOTEX INC | 29 Oct 2026 | 13 Nov 2026 | Manufacturing problem Disruption of the manufacture of the drug |
Source
Health Canada, Health Product Shortages Canada. Official list. Mandatory company reports since 2017: actual and anticipated shortages, plus products about to be discontinued.